Yoshiki Sekijima - Concepedia

Author

Yoshiki Sekijima

Also Known As

Arnt Kristen, Jae Hong Park, Marcia Waddington-Cruz, Marco Luigetti, Mitsuharu Ueda, Olivier Lairez, Ryoji Nishi, Sekijima, Yoshiki, Shu‐ichi Ikeda, Y Sekijima

436

Publications

14K

Citations

H-Index

189

Concepts

All Affiliations

Shinshu University Kumamoto University Shinshu University Hospital Scripps Research Institute Ōtani University

About

Yoshiki Sekijima is an author at Shinshu University specializing in medicine, neurology, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	59	3.3K
2	Health Sciences	6	6	219
3	Natural Sciences	4	4	505
4	Business	1	1	10
5	Engineering	1	1	72

Yoshiki Sekijima

127

Publications

11.5K

Citations

H-Index

Page 1

	Year	Citations
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis David Adams, Alejandra González‐Duarte, William O’Riordan, New England Journal of Medicine	2018	2.8K
Repurposing Diflunisal for Familial Amyloid Polyneuropathy John L. Berk, Ole B. Suhr, Laura Obici, JAMA	2013	679
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee Merrill D. Benson, Joel N. Buxbaum, David Eisenberg, Amyloid	2018	568
The Biological and Chemical Basis for Tissue-Selective Amyloid Disease Yoshiki Sekijima, R. Luke Wiseman, Jeanne Matteson, Cell Alzheimer's DiseaseTissue-selective Amyloid DiseaseBiochemistryDegenerative PathologyProtein Misfolding	2005	486
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee Merrill D. Benson, Joel N. Buxbaum, David Eisenberg, Amyloid	2020	400
Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene Hidetoshi Date, Osamu Onodera, Hajime Tanaka, Nature Genetics New HitMendelian DisorderOphthalmologyGenetic DisorderGenetics	2001	382
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial David Adams, Ivailo Tournev, Mark Taylor, Amyloid	2022	344
Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee Joel N. Buxbaum, Angela Dispenzieri, David Eisenberg, Amyloid Nomenclature CommitteePathologyNeurochemical BiomarkersAnalytical UltracentrifugationNeurobiology Of Disease	2022	299
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis Mathew S. Maurer, Parag Kale, Marianna Fontana, New England Journal of Medicine	2023	268
Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis Yoshiki Sekijima, Maria Dendle, Jeffery W. Kelly Amyloid	2006	263

Page 1